Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised
Outcome of written procedures finalised during the period from 4 March 2025 to 28 May 2025
Human medicines European public assessment report (EPAR): Jetrea, ocriplasmin, Date of authorisation: 13/03/2013, Revision: 15, Status: Withdrawn
Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 4, Status: Authorised
New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 April 2025 PRAC
How we work
Code of conduct of the European Medicines Agency
CVMP recommendations on limited market classification and eligibility for authorisation under Article 23
EMA’s 30th anniversary scientific conference - Medicines, regulation and the future, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 June 2025, 10:00 (CEST) to 25 June 2025, 16:00 (CEST)
Agenda - EMA’s 30th anniversary scientific conference